Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Koen van Besien

Showing results (111-120 of 241) with videos related to

Pageof 25
Sort By:
Leukemia & Lymphoma|May 26, 2010
Phase II study of immunomodulation with granulocyte-macrophage colony-stimulating factor, interleukin-2, and rituximab following autologous stem cell transplant in patients with relapsed or refractory lymphomasXavier Poiré, Justin Kline, David Grinblatt, et al.
Transfusion|February 6, 2015
How we handled the dextran shortage: an alternative washing or dilution solution for cord blood infusionsRonit Reich-Slotky, Lohith S Bachegowda, Michael Ancharski, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 11, 2002
Cutting edge: activation of the p38 mitogen-activated protein kinase signaling pathway mediates cytokine-induced hemopoietic suppression in aplastic anemiaAmit Verma, Dilip K Deb, Antonella Sassano, et al.
Transplantation|October 21, 2016
The Addition of Low-Dose Total Body Irradiation to Fludarabine and Melphalan Conditioning in Haplocord Transplantation for High-Risk Hematological MalignanciesHannah K Choe, Usama Gergis, Sebastian A Mayer, et al.
Cancer|January 12, 2013
A phase 2 study of epothilone B analog BMS-247550 (NSC 710428) in patients with relapsed aggressive non-Hodgkin lymphomasJane E Churpek, Barbara Pro, Koen van Besien, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 5, 2013
A phase 1 study of bendamustine and melphalan conditioning for autologous stem cell transplantation in multiple myelomaTomer M Mark, Whitney Reid, Ruben Niesvizky, et al.
Chimerism|April 26, 2014
Naturally acquired microchimerism: implications for transplantation outcome and novel methodologies for detectionMichael Eikmans, Astrid G S van Halteren, Koen van Besien, et al.
Journal of Clinical Pathology|January 26, 2018
Mycobacterial spindle cell pseudotumour: epidemiology and clinical outcomesMaroun M Sfeir, Audrey Schuetz, Koen Van Besien, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 1, 2020
Outcomes of Allogeneic Stem Cell Transplant for Elderly Patients with Hematologic MalignanciesJingmei Hsu, Zhengming Chen, Tsiporah Shore, et al.
Bone Marrow Transplantation|January 14, 2018
Management of important adverse events associated with inotuzumab ozogamicin: expert panel reviewPartow Kebriaei, Corey Cutler, Marcos de Lima, et al.
Pageof 25

Showing results (111-120 of 241) with videos related to

Sort By:
Pageof 25
Leukemia & Lymphoma|May 26, 2010
Phase II study of immunomodulation with granulocyte-macrophage colony-stimulating factor, interleukin-2, and rituximab following autologous stem cell transplant in patients with relapsed or refractory lymphomasXavier Poiré, Justin Kline, David Grinblatt, et al.
Transfusion|February 6, 2015
How we handled the dextran shortage: an alternative washing or dilution solution for cord blood infusionsRonit Reich-Slotky, Lohith S Bachegowda, Michael Ancharski, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 11, 2002
Cutting edge: activation of the p38 mitogen-activated protein kinase signaling pathway mediates cytokine-induced hemopoietic suppression in aplastic anemiaAmit Verma, Dilip K Deb, Antonella Sassano, et al.
Transplantation|October 21, 2016
The Addition of Low-Dose Total Body Irradiation to Fludarabine and Melphalan Conditioning in Haplocord Transplantation for High-Risk Hematological MalignanciesHannah K Choe, Usama Gergis, Sebastian A Mayer, et al.
Cancer|January 12, 2013
A phase 2 study of epothilone B analog BMS-247550 (NSC 710428) in patients with relapsed aggressive non-Hodgkin lymphomasJane E Churpek, Barbara Pro, Koen van Besien, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 5, 2013
A phase 1 study of bendamustine and melphalan conditioning for autologous stem cell transplantation in multiple myelomaTomer M Mark, Whitney Reid, Ruben Niesvizky, et al.
Chimerism|April 26, 2014
Naturally acquired microchimerism: implications for transplantation outcome and novel methodologies for detectionMichael Eikmans, Astrid G S van Halteren, Koen van Besien, et al.
Journal of Clinical Pathology|January 26, 2018
Mycobacterial spindle cell pseudotumour: epidemiology and clinical outcomesMaroun M Sfeir, Audrey Schuetz, Koen Van Besien, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 1, 2020
Outcomes of Allogeneic Stem Cell Transplant for Elderly Patients with Hematologic MalignanciesJingmei Hsu, Zhengming Chen, Tsiporah Shore, et al.
Bone Marrow Transplantation|January 14, 2018
Management of important adverse events associated with inotuzumab ozogamicin: expert panel reviewPartow Kebriaei, Corey Cutler, Marcos de Lima, et al.
Pageof 25